Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Neural Precursor Cell Expressed, Developmentally Down-Regulated 9 (NEDD9) (Middle Region) Peptid

NEDD9 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN980596
  • Target Alle NEDD9 Produkte
    NEDD9 (Neural Precursor Cell Expressed, Developmentally Down-Regulated 9 (NEDD9))
    Protein Region
    Middle Region
    Spezies
    Human
    Quelle
    • 5
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-NEDD9 antibody (Catalog #: ARP51211_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Aufreinigung
    Purified
  • Applikationshinweise
    Each Investigator should determine their own optimal working dilution for specific applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Konzentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    NEDD9 (Neural Precursor Cell Expressed, Developmentally Down-Regulated 9 (NEDD9))
    Synonyme
    NEDD9 Peptide, CAS-L Peptide, CAS2 Peptide, CASL Peptide, CASS2 Peptide, HEF1 Peptide, Cas-L Peptide, CasL Peptide, E230025G09Rik Peptide, neural precursor cell expressed, developmentally down-regulated 9 Peptide, neural precursor cell expressed, developmentally down-regulated gene 9 Peptide, NEDD9 Peptide, Nedd9 Peptide
    Hintergrund
    Variation in NEDD9 is associated wih susceptibility to late-onset Alzheimer and Parkinson diseases. Changes in expression of the scaffold protein HEF1/CAS-L/NEDD9 were found to be a potent prometastatic stimulus in melanoma and other cancers.

    Alias Symbols: CAS-L, CASL, HEF1, dJ49G10.2, dJ761I2.1, CAS2, CASS2

    Protein Interaction Partner: FZR1,SMAD3,ABL1,BCAR1,BCAR3,CDH1,CHAT,CRK,CRKL,DIMT1L,ELSPBP1,FYN,ID2,ITCH,LCK,LYN,MICAL1,NCK1,NEDD9,PTK2,PTK2B,PTPN11,PTPN12,PXN,RAPGEF1,SH2D3C,SMAD1,SMAD2,SMAD3,TCF3,TRIP6,ZYX,ABL1,BCAR1,BCAR3,CDH1,CRK,CRKL,ELSPBP1,FYN,ID2,ITCH,LCK,LYN,MICAL1,NCK1,NEDD9,PTK2,PTK2B,PTPN12,PXN,RAPGEF1,SH2D3C,SMAD1,SMAD2,SMAD3,TRIP6,ZYX

    Protein Size: 834
    Molekulargewicht
    93 kDa
    Gen-ID
    4739
    NCBI Accession
    NM_006403, NP_006394
    UniProt
    Q14511
Sie sind hier:
Kundenservice